Remove Biotechnology Remove Healthcare Remove Life Sciences Remove Telemedicine
article thumbnail

Healthcare & Life Science M&A Activity Plummets 1H’22

HIT Consultant

What You Should Know: – The index of Healthcare & Life Science equities tracked by Stout was down 16.8% – Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. Key Trends and Market Summary. from $34.61

article thumbnail

Cerner/Livongo Exec Joins Quantum Health, UPMC, Other Executive Appointments

HIT Consultant

Quantum Health , the industry leader in healthcare navigation and care coordination, announced that Zane Burke has joined the company as chief executive officer and member of the company’s Board of Directors. Benchling , pioneer of the R&D Cloud powering the biotechnology industry appoints Lindsey Irvine as Chief Marketing Officer.